摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-甲氧基乙氧基)-2-甲基-2-丙醇 | 211321-90-3

中文名称
1-(2-甲氧基乙氧基)-2-甲基-2-丙醇
中文别名
——
英文名称
1-(2-methoxyethoxy)-2-methylpropan-2-ol
英文别名
1-(2-Methoxyethoxy)-2-methyl-2-propanol
1-(2-甲氧基乙氧基)-2-甲基-2-丙醇化学式
CAS
211321-90-3
化学式
C7H16O3
mdl
MFCD03095426
分子量
148.202
InChiKey
SIUWDFVMEASCRP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    0.953 g/mL at 20 °C(lit.)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    10
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    38.7
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • WGK Germany:
    3

SDS

SDS:355c49e99e376bd388f92bab8f1ff99b
查看

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : 1-(2-Methoxyethoxy)-2-methyl-2-propanol
CAS-No. : 211321-90-3
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances



Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No 1272/2008
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
Caution - substance not yet tested completely.
Other hazards - none

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C7H16O3
Molecular Weight : 148,20 g/mol

Section 4. FIRST AID MEASURES
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
Indication of any immediate medical attention and special treatment needed
no data available

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Avoid breathing vapors, mist or gas.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Normal measures for preventive fire protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
opened must be carefully resealed and kept upright to prevent leakage.
Specific end uses
no data available

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
impervious clothing, The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection not required. For nuisance exposures use type OV/AG (US) or type ABEK
(EU EN 14387) respirator cartridges. Use respirators and components tested and approved under
appropriate government standards such as NIOSH (US) or CEN (EU).

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: liquid, clear
Colour: colourless
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density 0,953 g/cm3 at 20 °C
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Additional Information
RTECS: Not available

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
no data available

Section 16. OTHER INFORMATION
Further information
Copyright 2012 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

反应信息

  • 作为反应物:
    描述:
    1-(2-甲氧基乙氧基)-2-甲基-2-丙醇sodium 作用下, 以 正己烷 为溶剂, 生成
    参考文献:
    名称:
    带有供体官能化的醇盐配体的铟络合物作为氧化铟薄膜的前体
    摘要:
    新颖铟配合物[(CH 3)2在(OR)] 2(1 - 7)使用一系列供体的合成-官能化的醇盐配体作为用于薄膜应用中具有潜在的前体。这些配合物显示出具有两个μ二聚体构2 -O金属中心之间的桥接。此外,这些络合物中的铟金属中心表现出五配位态,具有扭曲的三角-双锥体几何形状。通过傅立叶变换(FT)红外和FT核磁共振光谱,元素分析和热重分析(TGA)对复合物进行表征。配合物4和7的TGA曲线 在100–275°C时表现出单步质量损失,表明具有良好的挥发性和热稳定性。
    DOI:
    10.1016/j.jorganchem.2017.01.019
  • 作为产物:
    描述:
    甲基环氧丙烷乙二醇甲醚 在 sodium hydride 作用下, 以 四氢呋喃 为溶剂, 反应 12.5h, 以45%的产率得到1-(2-甲氧基乙氧基)-2-甲基-2-丙醇
    参考文献:
    名称:
    Heteroleptic strontium complexes stabilized by donor-functionalized alkoxide and β-diketonate ligands
    摘要:
    配体配位位点处的体积对异配位锶配合物的结构特征产生影响。
    DOI:
    10.1039/c5dt01356a
点击查看最新优质反应信息

文献信息

  • METAL ALKOXIDE COMPOUND, THIN-FILM-FORMING MATERIAL, METHOD FOR PRODUCING THIN FILM, AND ALCOHOL COMPOUND
    申请人:ADEKA CORPORATION
    公开号:US20150175642A1
    公开(公告)日:2015-06-25
    Disclosed is a metal alkoxide compound having physical properties suitable for a material for forming thin films by CVD, and particularly, a metal alkoxide compound having physical properties suitable for a material for forming metallic-copper thin films. A metal alkoxide compound is represented by general formula (I). A thin-film-forming material including the metal alkoxide compound is described as well. (In the formula, R 1 represents a methyl group or an ethyl group, R 2 represents a hydrogen atom or a methyl group, R 3 represents a C 1-3 linear or branched alkyl group, M represents a metal atom or a silicon atom, and n represents the valence of the metal atom or silicon atom.
    揭示了一种具有适合用于CVD形成薄膜材料的物理性质的属烷氧化物化合物,特别是一种具有适合用于形成薄膜材料的属烷氧化物化合物。属烷氧化物化合物由通式(I)表示。还描述了包括属烷氧化物化合物的薄膜形成材料。(在公式中,R1代表甲基基团或乙基基团,R2代表氢原子或甲基基团,R3代表C1-3直链或支链烷基基团,M代表属原子或原子,n代表属原子或原子的价。
  • ORGANOMETALLIC COMPOUND AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT USING THE SAME
    申请人:SAMSUNG ELECTRONICS CO., LTD.
    公开号:US20210388010A1
    公开(公告)日:2021-12-16
    An organometallic compound and a method of manufacturing an integrated circuit (IC) device, the organometallic compound being represented by Formula (I),
    一种有机属化合物和一种制造集成电路(IC)器件的方法,该有机属化合物由式(I)表示,
  • Novel Compounds For The Treatment Of GI Disorders 682
    申请人:Bauer Udo
    公开号:US20080262064A1
    公开(公告)日:2008-10-23
    The present invention relates to novel imidazole compounds having a positive allosteric GABA B receptor (CUR) modulator effect, methods for the preparation of said compounds and to their use, optionally in combination with a GABA B agonist, for the inhibition of transient lower esophageal sphincter relaxations, for the treatment of gastroesophageal reflux disease, as well as for the treatment of functional gastrointestinal disorders and irritable bowel syndrome (IBS).
    本发明涉及具有正向别构GABAB受体(CUR)调节剂作用的新型咪唑化合物,以及所述化合物的制备方法及其使用,可选地与GABAB激动剂结合,用于抑制瞬时下食管括约肌松弛,用于治疗胃食管反流病,以及用于治疗功能性胃肠疾病和肠易激综合征(IBS)。
  • ALUMINUM COMPOUND AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE USING THE SAME
    申请人:Samsung Electronics Co., Ltd.
    公开号:US20200207790A1
    公开(公告)日:2020-07-02
    Provided are an aluminum compound and a method for manufacturing a semiconductor device using the same. The aluminum compound may be represented by Formula 1.
    提供了一种铝化合物以及使用它制造半导体器件的方法。该铝化合物可用公式1表示。
  • [EN] NOVEL HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS<br/>[FR] NOUVEAUX COMPOSÉS HÉTÉROCYCLIQUES ET LEUR UTILISATION POUR PRÉVENIR OU TRAITER DES INFECTIONS BACTÉRIENNES
    申请人:MUTABILIS
    公开号:WO2018141991A1
    公开(公告)日:2018-08-09
    The present invention relates to compound of formula (I) and their use for treating bacterial infections.
    本发明涉及化合物的公式(I)以及它们用于治疗细菌感染的用途。
查看更多